URL | Priority | Change frequency | Last modified (GMT) |
---|---|---|---|
https://www.iconbioscience.com/news/icon-bioscience-announces-pivotal-phase-3-clinical-data-demonstrates-exceptional-efficacy-of-ibi-10090-in-reducing-inflammation-associated-with-cataract-surgery | 20% | Monthly | 2019-08-01 08:49 |